ArticleMayo Clinic proceedings2016

5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia.

Lauren P Wallner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.